BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 21762573)

  • 21. [Multibacillary leprosy recurrences].
    Rodríguez G; Pinto R; Laverde C; Sarmiento M; Riveros A; Valderrama J; Ordóñez N
    Biomedica; 2004 Sep; 24(3):332-4. PubMed ID: 15551886
    [No Abstract]   [Full Text] [Related]  

  • 22. Cluster of leprosy cases in Kona, Hawaii; impact of the Compact of Free Association.
    Ong AK; Frankel RI; Maruyama MH
    Int J Lepr Other Mycobact Dis; 1999 Mar; 67(1):13-8. PubMed ID: 10407624
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relapse with multibacillary leprosy caused by rifampicin sensitive organisms following paucibacillary multidrug therapy.
    Soares DJ; Neupane K; Britton WJ
    Lepr Rev; 1995 Sep; 66(3):210-3. PubMed ID: 7500815
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hansen's Disease in the United States.
    Hudson T; Genesse J
    Soc Sci Med; 1982; 16(9):997-1004. PubMed ID: 7051335
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk of relapse in multibacillary leprosy.
    Jakeman P
    Lancet; 1995 Jan; 345(8941):4-5. PubMed ID: 7799708
    [No Abstract]   [Full Text] [Related]  

  • 26. Relapses in multibacillary leprosy patients after multidrug therapy.
    Poojabylaiah M; Marne RB; Varikkodan R; Bala N; Dandakeri S; Martis J
    Lepr Rev; 2008 Sep; 79(3):320-4. PubMed ID: 19009982
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of PCR mediated amplification of DNA and the classical methods for detection of Mycobacterium leprae in different types of clinical samples in leprosy patients and contacts.
    Torres P; Camarena JJ; Gomez JR; Nogueira JM; Gimeno V; Navarro JC; Olmos A
    Lepr Rev; 2003 Mar; 74(1):18-30. PubMed ID: 12669929
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A forgotten old disease.
    Cataño JC; Gomez SI
    Eur J Intern Med; 2017 Oct; 44():e5-e6. PubMed ID: 28238568
    [No Abstract]   [Full Text] [Related]  

  • 29. Analysis of socioeconomic condition and bacillary index with respect to the development of Hansen's disease.
    Gautam S; Sharma D; Singh S; Arora M; Goel A; Bisht D
    Int J Mycobacteriol; 2023; 12(3):254-260. PubMed ID: 37721229
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A 6 week quadruple drug regimen for the treatment of multibacillary leprosy.
    Pattyn S; Grillone S
    Lepr Rev; 2000 Mar; 71(1):43-6. PubMed ID: 10820986
    [No Abstract]   [Full Text] [Related]  

  • 31. Leprosy in Nonimmigrant Canadian Man without Travel outside North America, 2014.
    Bonnar PE; Cunningham NP; Boggild AK; Walsh NM; Sharma R; Davis IRC
    Emerg Infect Dis; 2018 Jan; 24(1):165-166. PubMed ID: 29260666
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Should large lesions of leprosy be considered as "multibacillary" for treatment purposes even if the total number of lesions is less than five?
    Kumarasinghe SP; Kumarasinghe MP
    Int J Lepr Other Mycobact Dis; 2004 Jun; 72(2):173-4. PubMed ID: 15301583
    [No Abstract]   [Full Text] [Related]  

  • 33. Leprosy and international adoption: a case report and review of diagnostic and treatment dilemmas.
    King K; Browning JC; Metry DW; Prestigiacomo J; Scollard D; Schutze GE; Stryjewska B; Schwarzwald H
    Pediatr Infect Dis J; 2009 Apr; 28(4):322-5. PubMed ID: 19238115
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Leprosy--a disease of the Schwann cell.
    Antia NH
    Lepr India; 1982 Oct; 54(4):599-604. PubMed ID: 6763963
    [No Abstract]   [Full Text] [Related]  

  • 35. Acedapsone (DADDS) treatment of leprosy patients in the Karimui of Papua New Guinea: status at six years.
    Russell DA; Shepard CC; McRae DH; Scott GC; Vincin DR
    Am J Trop Med Hyg; 1975 May; 24(3):485-95. PubMed ID: 1098496
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Time to define leprosy elimination as zero leprosy transmission?
    Smith CS; Aerts A; Kita E; Virmond M
    Lancet Infect Dis; 2016 Apr; 16(4):398-9. PubMed ID: 27036335
    [No Abstract]   [Full Text] [Related]  

  • 37. Are 18 doses of WHO/MDT sufficient for multibacillary leprosy; results of a trial in Malawi.
    Pönnighaus JM; Boerrigter G
    Int J Lepr Other Mycobact Dis; 1995 Mar; 63(1):1-7. PubMed ID: 7730703
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Single-dose treatment for paucibacillary leprosy; field implications.
    Revankar CR; Pai VV; Samy MS; Ganapati R
    Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):312-4. PubMed ID: 10575415
    [No Abstract]   [Full Text] [Related]  

  • 39. A case of leprosy in a nonendemic country.
    Asperges E; Bagnarino J; Ancarani C; Baggini G; Filardo M; Monzillo V; Barbarini D; Bruno R; Paulli M; Baldanti F
    Int J Infect Dis; 2024 Jun; 143():107004. PubMed ID: 38479578
    [No Abstract]   [Full Text] [Related]  

  • 40. Evidence for
    Mahajan NP; Lavania M; Singh I; Nashi S; Preethish-Kumar V; Vengalil S; Polavarapu K; Pradeep-Chandra-Reddy C; Keerthipriya M; Mahadevan A; Yasha TC; Nandeesh BN; Gnanakumar K; Parry GJ; Sengupta U; Nalini A
    Am J Trop Med Hyg; 2020 Mar; 102(3):547-552. PubMed ID: 31933458
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.